Hsbc Holdings PLC Increases Stake in Novanta Inc. $NOVT

Hsbc Holdings PLC lifted its stake in shares of Novanta Inc. (NASDAQ:NOVT) by 1,355.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 185,155 shares of the technology company’s stock after buying an additional 172,435 shares during the quarter. Hsbc Holdings PLC owned approximately 0.52% of Novanta worth $21,964,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC lifted its stake in Novanta by 75.9% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,399,462 shares of the technology company’s stock worth $155,536,000 after acquiring an additional 604,055 shares during the last quarter. GW&K Investment Management LLC increased its position in shares of Novanta by 187.3% in the 4th quarter. GW&K Investment Management LLC now owns 736,954 shares of the technology company’s stock valued at $87,691,000 after purchasing an additional 480,413 shares during the last quarter. Sculptor Capital LP acquired a new stake in shares of Novanta in the 4th quarter valued at $51,265,000. Norges Bank acquired a new stake in shares of Novanta in the 4th quarter valued at $50,719,000. Finally, Schroder Investment Management Group lifted its position in shares of Novanta by 206.1% during the 4th quarter. Schroder Investment Management Group now owns 600,146 shares of the technology company’s stock worth $72,540,000 after purchasing an additional 404,097 shares during the last quarter. 98.35% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

NOVT has been the subject of a number of analyst reports. Wall Street Zen downgraded shares of Novanta from a “buy” rating to a “hold” rating in a research note on Saturday, April 18th. Weiss Ratings restated a “hold (c-)” rating on shares of Novanta in a research note on Friday, April 17th. Finally, Robert W. Baird set a $180.00 price target on Novanta in a report on Tuesday, June 9th. One analyst has rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $180.00.

Novanta Stock Performance

Shares of Novanta stock opened at $152.00 on Thursday. The company has a quick ratio of 2.69, a current ratio of 3.56 and a debt-to-equity ratio of 0.15. Novanta Inc. has a 52 week low of $98.27 and a 52 week high of $171.85. The firm’s 50 day moving average is $148.44 and its two-hundred day moving average is $135.14. The firm has a market capitalization of $5.41 billion, a P/E ratio of 110.15 and a beta of 1.68.

Novanta (NASDAQ:NOVT) last issued its earnings results on Monday, May 11th. The technology company reported $0.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.78 by $0.03. The business had revenue of $257.71 million during the quarter, compared to analysts’ expectations of $253.40 million. Novanta had a net margin of 5.35% and a return on equity of 12.06%. The company’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.74 EPS. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. Research analysts forecast that Novanta Inc. will post 3.59 EPS for the current fiscal year.

Insider Transactions at Novanta

In other Novanta news, CEO Matthijs Glastra sold 7,500 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $150.43, for a total transaction of $1,128,225.00. Following the transaction, the chief executive officer owned 42,761 shares of the company’s stock, valued at approximately $6,432,537.23. This trade represents a 14.92% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.20% of the stock is owned by corporate insiders.

Novanta Profile

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.